187. 歌舞伎症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 4 / 薬物数 : 6 - (DrugBank : 2) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 17
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Genotropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Intervention ON primary cultured cells
University Hospital, Montpellier
2020 - NCT03855631 France
Modified atkins diet
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
2021 Early Phase 1 NCT04722315 United States
Recombinant DNA-derived human growth hormone
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Risperidone
Child Psychopharmacology Institute
2008 - NCT00723580 United States
Somatropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Intervention ON primary cultured cells
University Hospital, Montpellier
2020 - NCT03855631 France
Modified atkins diet
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
2021 Early Phase 1 NCT04722315 United States
Recombinant DNA-derived human growth hormone
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Risperidone
Child Psychopharmacology Institute
2008 - NCT00723580 United States
Somatropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands